Works matching IS 00126667 AND DT 2024 AND VI 84 AND IP 9


Results: 12
    1
    2

    Ensifentrine: First Approval.

    Published in:
    Drugs, 2024, v. 84, n. 9, p. 1157, doi. 10.1007/s40265-024-02081-w
    By:
    • Keam, Susan J.
    Publication type:
    Article
    3
    4

    Imetelstat: First Approval.

    Published in:
    Drugs, 2024, v. 84, n. 9, p. 1149, doi. 10.1007/s40265-024-02080-x
    By:
    • Keam, Susan J.
    Publication type:
    Article
    5
    6

    Elafibranor: First Approval.

    Published in:
    Drugs, 2024, v. 84, n. 9, p. 1143, doi. 10.1007/s40265-024-02075-8
    By:
    • Blair, Hannah A.
    Publication type:
    Article
    7
    8
    9

    Therapeutic Potential of FXI Inhibitors: Hype or Hope?

    Published in:
    Drugs, 2024, v. 84, n. 9, p. 1055, doi. 10.1007/s40265-024-02049-w
    By:
    • Galli, Mattia;
    • Occhipinti, Giovanni;
    • Ortega-Paz, Luis;
    • Franchi, Francesco;
    • Rollini, Fabiana;
    • Brugaletta, Salvatore;
    • Capodanno, Davide;
    • Sciarretta, Sebastiano;
    • Angiolillo, Dominick J.
    Publication type:
    Article
    10

    Ivonescimab: First Approval.

    Published in:
    Drugs, 2024, v. 84, n. 9, p. 1135, doi. 10.1007/s40265-024-02073-w
    By:
    • Dhillon, Sohita
    Publication type:
    Article
    11
    12